CN107501199A - The extraction of fluorine thunder Rana monomeric compound and purification process - Google Patents
The extraction of fluorine thunder Rana monomeric compound and purification process Download PDFInfo
- Publication number
- CN107501199A CN107501199A CN201710701591.9A CN201710701591A CN107501199A CN 107501199 A CN107501199 A CN 107501199A CN 201710701591 A CN201710701591 A CN 201710701591A CN 107501199 A CN107501199 A CN 107501199A
- Authority
- CN
- China
- Prior art keywords
- silica gel
- extraction
- petroleum ether
- chromatography column
- dichloromethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 35
- 238000000605 extraction Methods 0.000 title claims description 31
- 238000000746 purification Methods 0.000 title claims description 10
- 229910052731 fluorine Inorganic materials 0.000 title description 2
- 239000011737 fluorine Substances 0.000 title description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 title 1
- 241000269435 Rana <genus> Species 0.000 title 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 93
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 55
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 54
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 46
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000000741 silica gel Substances 0.000 claims abstract description 43
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 43
- MLBZKOGAMRTSKP-UHFFFAOYSA-N fluralaner Chemical compound C1=C(C(=O)NCC(=O)NCC(F)(F)F)C(C)=CC(C=2CC(ON=2)(C=2C=C(Cl)C=C(Cl)C=2)C(F)(F)F)=C1 MLBZKOGAMRTSKP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000003208 petroleum Substances 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 34
- 238000000944 Soxhlet extraction Methods 0.000 claims abstract description 27
- 229940104542 bravecto Drugs 0.000 claims abstract description 22
- 239000000287 crude extract Substances 0.000 claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 13
- 239000011259 mixed solution Substances 0.000 claims abstract description 12
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 238000013375 chromatographic separation Methods 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 239000002027 dichloromethane extract Substances 0.000 claims abstract description 5
- 239000000047 product Substances 0.000 claims description 14
- 239000000178 monomer Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 4
- 238000003808 methanol extraction Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 238000000967 suction filtration Methods 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 20
- 238000001514 detection method Methods 0.000 abstract description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 229960004498 fluralaner Drugs 0.000 description 18
- 239000005899 Fipronil Substances 0.000 description 17
- 229940013764 fipronil Drugs 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 241000238631 Hexapoda Species 0.000 description 15
- 239000003814 drug Substances 0.000 description 15
- 238000002390 rotary evaporation Methods 0.000 description 15
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 14
- 239000012535 impurity Substances 0.000 description 14
- 241000238657 Blattella germanica Species 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 229940079593 drug Drugs 0.000 description 10
- 239000002917 insecticide Substances 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000011521 glass Substances 0.000 description 9
- 230000000749 insecticidal effect Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 238000009395 breeding Methods 0.000 description 7
- 230000001018 virulence Effects 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 241000426499 Chilo Species 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 5
- 241000607479 Yersinia pestis Species 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000003828 vacuum filtration Methods 0.000 description 5
- 108010062745 Chloride Channels Proteins 0.000 description 4
- 102000011045 Chloride Channels Human genes 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 4
- 229950001327 dichlorvos Drugs 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- -1 isoxazole compound Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000004570 mortar (masonry) Substances 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 229960000490 permethrin Drugs 0.000 description 4
- 230000000384 rearing effect Effects 0.000 description 4
- 238000012827 research and development Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 241000426497 Chilo suppressalis Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000258242 Siphonaptera Species 0.000 description 3
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical class CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- HVQHXBNMBZJPLK-UHFFFAOYSA-N 1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methylprop-2-en-1-yl)amino]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound CC(=C)CNC1=C([S+]([O-])C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl HVQHXBNMBZJPLK-UHFFFAOYSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000255967 Helicoverpa zea Species 0.000 description 2
- 239000005906 Imidacloprid Substances 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241001674048 Phthiraptera Species 0.000 description 2
- 241000238680 Rhipicephalus microplus Species 0.000 description 2
- 241000256251 Spodoptera frugiperda Species 0.000 description 2
- 241001454293 Tetranychus urticae Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical class C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940056881 imidacloprid Drugs 0.000 description 2
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 150000002547 isoxazolines Chemical class 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 150000008048 phenylpyrazoles Chemical class 0.000 description 2
- 239000002287 radioligand Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- KAATUXNTWXVJKI-NSHGMRRFSA-N (1R)-cis-(alphaS)-cypermethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-NSHGMRRFSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- 235000011371 Brassica hirta Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- 241001498622 Cixius wagneri Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000258924 Ctenocephalides felis Species 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000995027 Empoasca fabae Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- FNELVJVBIYMIMC-UHFFFAOYSA-N Ethiprole Chemical compound N1=C(C#N)C(S(=O)CC)=C(N)N1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl FNELVJVBIYMIMC-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000927584 Frankliniella occidentalis Species 0.000 description 1
- 102000005915 GABA Receptors Human genes 0.000 description 1
- 108010005551 GABA Receptors Proteins 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 241001470017 Laodelphax striatella Species 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241000257166 Lucilia cuprina Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000004535 Papaipema leucostigma Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241001414989 Thysanoptera Species 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000021405 artificial diet Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229950006824 dieldrin Drugs 0.000 description 1
- DFBKLUNHFCTMDC-PICURKEMSA-N dieldrin Chemical compound C([C@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@H]2[C@@H]2[C@H]1O2 DFBKLUNHFCTMDC-PICURKEMSA-N 0.000 description 1
- NGPMUTDCEIKKFM-UHFFFAOYSA-N dieldrin Natural products CC1=C(Cl)C2(Cl)C3C4CC(C5OC45)C3C1(Cl)C2(Cl)Cl NGPMUTDCEIKKFM-UHFFFAOYSA-N 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- NAYYNDKKHOIIOD-UHFFFAOYSA-N phthalamide Chemical compound NC(=O)C1=CC=CC=C1C(N)=O NAYYNDKKHOIIOD-UHFFFAOYSA-N 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明公开一种氟雷拉纳单体化合物的提取和纯化方法,包括如下步骤:1)Bravecto制剂粉碎成粉末后,依次用石油醚、二氯甲烷、甲醇进行索式提取直至回流液澄清,将二氯甲烷提取液或三种提取液分别低压旋转蒸发得到粗提物;2)称取与粗提物等质量的硅胶,石油醚溶解后倒入层析柱,记为1个高度单位,再加入6~8个高度单位的硅胶;3)将步骤1)获得的粗提物加入层析柱内;4)用不同体积比的石油醚‑乙酸乙酯混合溶液进行层析分离,得到目标产物。本发明所述方法可以成功从Bravecto中提取得到高纯度的氟雷拉纳化合物,满足对该化合物的需求问题或检测检验等问题。The invention discloses a method for extracting and purifying a monomeric compound of Frellana, which comprises the following steps: 1) After the Bravecto preparation is pulverized into powder, sequentially use petroleum ether, methylene chloride and methanol for Soxhlet extraction until the reflux liquid is clarified, The dichloromethane extract or the three extracts were rotatably evaporated at low pressure to obtain the crude extract; 2) Weigh the silica gel with the same mass as the crude extract, dissolve it in petroleum ether and pour it into the chromatographic column, record it as 1 height unit, Then add 6 to 8 height units of silica gel; 3) Add the crude extract obtained in step 1) into the chromatography column; 4) Perform chromatographic separation with mixed solutions of petroleum ether-ethyl acetate in different volume ratios to obtain the target product. The method of the present invention can successfully extract the high-purity Frellaner compound from Bravecto, which satisfies the demand for the compound or the detection and testing problems.
Description
技术领域technical field
本发明涉及药物化学及生物医药领域,具体而言,涉及一种新型异噁唑类化合物氟雷拉纳的提取和纯化方法及其在生产、生活中的应用。The invention relates to the fields of medicinal chemistry and biomedicine, in particular to a method for extracting and purifying a novel isoxazole compound, Frellana, and its application in production and life.
背景技术Background technique
异噁唑啉类(Isoxazoline)化合物是在研究邻苯二甲酸甲酰胺(phthalicdiamide)和邻甲酰氨基苯甲酰胺(anthranilic diamide)过程中获得的一类新型杀虫活性物质。目前,全球各国的科研团队,如日本、美国和欧洲等地区,均已展开对该类化合物的研发及其作用机理的研究。Isoxazoline compounds are a new class of insecticidal active substances obtained during the study of phthalic diamide and anthranilic diamide. At present, scientific research teams from various countries around the world, such as Japan, the United States, and Europe, have launched the research and development of this type of compound and its mechanism of action.
新型异噁唑类化合物氟雷拉纳,其特征在于:研发代号为A1443,化学名称为4,5-[(3,5-二氯苯基)-4,5-二氢-5-三氟甲基-3-异唑基]-2-甲基-氮-[2-氧代-2-[(2,2,2-三氟乙基)氨基]乙基]-苯甲酰胺,具有对映异构体结构,其化学结构式为:The novel isoxazole compound Freilaner is characterized in that: the research and development code is A1443, and the chemical name is 4,5-[(3,5-dichlorophenyl)-4,5-dihydro-5-trifluoro Methyl-3-isoxazolyl]-2-methyl-nitrogen-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-benzamide, with p- Enantiomer structure, its chemical structural formula is:
氟雷拉纳研发历程大致如下:2004年,日本日产化学工业株式会社Mita等成功合成氟雷拉纳。2010年,Ozoe等详细研究了氟雷拉纳的部分生物和电生理活性。2013年,García-Reynaga等合成了放射性配基[3H]氟雷拉纳,用于研究氟雷拉纳在γ-氨基丁酸(GABA)受体的作用位点和机制。2014年,Zhao(第一发明人)等比较研究了氟雷拉纳及其类似物在昆虫和哺乳动物GABA受体的作用位点;Gassel等和Rohdich等报道了氟雷拉纳对虱和跳蚤的生物活性;德国动物卫生创新研究所的研究者利用氟雷拉纳对狗做了系列“临床试验”,检测了氟雷拉纳对狗寄生虫的生物活性以及对狗的毒性等;同年氟雷拉纳被美国食品与药品监督管理局批准上市(商品名Bravecto)在欧美市场销售,季度销售额达1亿美元。The research and development process of Frellana is roughly as follows: In 2004, Japan’s Nissan Chemical Industry Co., Ltd. Mita and others successfully synthesized Frellana. In 2010, Ozoe et al. studied some of the biological and electrophysiological activities of Frellana in detail. In 2013, García-Reynaga et al. synthesized the radioligand [ 3 H] Frellaner, which was used to study the action site and mechanism of Frellaner at the γ-aminobutyric acid (GABA) receptor. In 2014, Zhao (the first inventor) et al comparatively studied the action sites of Frellana and its analogues on the GABA receptors of insects and mammals; Gassel et al. and Rohdich et al. The biological activity of the animal health innovation institute in Germany; the researchers of the German Animal Health Innovation Institute used Frellana to conduct a series of "clinical tests" on dogs, and tested the biological activity of Frellana on dog parasites and its toxicity to dogs; Lei Lana was approved by the US Food and Drug Administration (trade name Bravecto) to be sold in the European and American markets, with quarterly sales of 100 million US dollars.
氟雷拉纳主要通过干扰GABA门控氯离子通道发挥作用,与环戊二烯类、苯基吡唑类和大环内酯类等杀虫剂的作用靶标类似。氟雷拉纳的成功研发开创了一类全新的GABA门控氯离子通道干扰剂研究方向,引起了动物医学和农药科学工作者的关注和青睐。氟雷拉纳是一种广谱性杀虫剂,对蜱目、蚤目、虱目、半翅目和双翅目等害虫均具有良好的杀虫活性,其毒力高于或与常用杀虫剂相当。氟雷拉纳对栉头蚤(Ctenocephalides felis)的活性优于传统杀虫剂氟虫腈和吡虫啉;对于铜绿蝇(Lucilia cuprina)的活性高于氟虫腈、狄氏剂、吡虫啉和溴氰菊酯;对于微小牛蜱(Rhipicephalus microplus)的活性远高于溴氰菊酯,对抗氟虫腈的灰飞虱(Laodelphax striatellus)和二斑叶螨(Tetranychus urticae)的杀虫活性也较好。氟雷拉纳不仅与现有杀虫剂无显著的交互抗性,甚至对部分抗性害虫也具有较好的杀虫活性。美国杜邦公司Lahm等报道了一系列与氟雷拉纳结构类似的异噁唑啉类化合物,该类化合物对鳞翅目,如草地贪夜蛾(Spodoptera frugiperda)和棉铃虫(Helicoverpa zea);同翅目,如蚕虫微叶(Empoasca fabae)和缨翅目,如西花蓟马(Frankliniella occidentalis)等害虫均表现出良好的杀虫活性。此外,Zhao(第一申请人)等通过放射性配基竞争性结合试验发现,氟雷拉纳对体外重组表达的人GABA门控氯离子通道(β3亚基)几乎无作用。Frelaner mainly works by interfering with GABA-gated chloride ion channels, which are similar to the targets of pesticides such as cyclopentadienes, phenylpyrazoles and macrolides. The successful research and development of Frellana has created a new research direction of GABA-gated chloride channel disruptors, which has attracted the attention and favor of veterinary medicine and pesticide scientists. Frellana is a broad-spectrum insecticide, which has good insecticidal activity against pests such as ticks, fleas, lice, hemiptera and diptera, and its toxicity is higher than or equal to that of commonly used insecticides. Insecticides are comparable. Frellana is more active against Ctenocephalides felis than traditional insecticides fipronil and imidacloprid; more active against copper fly (Lucilia cuprina) than fipronil, dieldrin, imidacloprid and deltamethrin Esters; the activity against tiny cattle ticks (Rhipicephalus microplus) is much higher than that of deltamethrin, and the insecticidal activity against fipronil-resistant white planthopper (Laodelphax striatellus) and two-spotted spider mite (Tetranychus urticae) is also better. Not only does Freilaner have no significant cross-resistance with existing insecticides, it even has good insecticidal activity against partially resistant pests. U.S. DuPont Company Lahm etc. have reported a series of isoxazoline compounds similar to Freylana structure, this class compound is to Lepidoptera, as Spodoptera frugiperda (Spodoptera frugiperda) and cotton bollworm (Helicoverpa zea); Pests of the order of Pteroptera, such as Empoasca fabae and of the order of Thysanoptera, such as Frankliniella occidentalis, have shown good insecticidal activity. In addition, Zhao (the first applicant) et al. found through radioligand competitive binding experiments that Freilaner had almost no effect on recombinantly expressed human GABA-gated chloride channels (β3 subunits) in vitro.
目前,氟雷拉纳作为兽药已完成商品化运作,被应用于寄生虫的防治。自2013年至今,德国动物卫生创新研究所的科研工作者对氟雷拉纳开展了一系列试验研究,采用口服饲喂的方法比较研究了氟雷拉纳、氟虫腈(Frontline)和溴氰菊酯(Scalibor)对狗寄生虫栉头蚤和变异革蜱的防治效果。结果表明,氟雷拉纳对栉头蚤和扁虱具有非常好的除杀效果。2014年,默克公司首次以氟雷拉纳作为兽药Bravecto进行了商业化生产,用于杀灭狗寄生虫虱子和跳蚤等。一系列的研究表明,该药物可被狗体迅速吸收,具有见效快、半衰期长、持效期长及代谢率低等特点。目前该药已获得美国FDA的许可认证,并在欧洲和美国等国家开始销售和推广,预计其在亚洲乃至中国的推广也指日可待。At present, Frellana has been commercialized as a veterinary drug and has been applied to the prevention and control of parasites. Since 2013, researchers at the German Institute for Animal Health Innovation have carried out a series of experimental studies on Frellana, using oral feeding methods to compare and study Frellana, Fipronil (Frontline) and bromide Control effect of permethrin (Scalibor) against dog parasites Ctencephalitus and Dermatitis variabilis. The results showed that Frellana had a very good killing effect on comb fleas and ticks. In 2014, Merck first commercialized Frellana as the veterinary drug Bravecto, which is used to kill dog parasites such as lice and fleas. A series of studies have shown that the drug can be quickly absorbed by dogs, and has the characteristics of quick effect, long half-life, long-lasting effect and low metabolic rate. At present, the drug has been approved by the FDA of the United States, and has begun to be sold and promoted in countries such as Europe and the United States. It is expected that its promotion in Asia and even China is just around the corner.
Fluralaner作为一种新型异恶唑类杀虫剂,主要通过干扰GABA门控氯离子通道发挥作用,与环戊二烯类、苯基吡唑类和大环内酯类等杀虫剂的作用靶标类似。但是目前的研究发现,fluralaner与氟虫腈、乙虫腈、丁烯氟虫腈、阿维菌素等传统GABA受体标靶杀虫剂作用机制不同,而对于其作用机制的研究和发现在昆虫抗药性中具有极其重要的作用和意义。Fluralaner单体化合物区别于Bravecto制剂,在实验研究中具有其特定的研究意义。目前,fluralaner单体化合物在实验研究中需求量很大,但尚无法在市面上购买到,且合成路线复杂,技术难度高。因此,fluralaner的获取成为亟待解决的问题。Fluralaner, as a new type of isoxazole insecticide, mainly acts by interfering with GABA-gated chloride ion channels, and interacts with the targets of cyclopentadienes, phenylpyrazoles and macrolides and other insecticides similar. However, current studies have found that fluralaner has a different mechanism of action from traditional GABA receptor-targeted insecticides such as fipronil, ethiprole, butylene fipronil, and abamectin. It plays an extremely important role and significance in insect resistance. The Fluralaner monomer compound is different from the Bravecto preparation, and has its specific research significance in experimental research. At present, fluralaner monomer compounds are in great demand in experimental research, but they are not yet available in the market, and the synthetic route is complex and technically difficult. Therefore, the acquisition of fluralaner has become an urgent problem to be solved.
Bravecto是一种新药且成分较复杂,其中fluralaner的含量只有14%,通过HPLC-TOF-MS检测发现其中存在与fluralaner极性极为接近的杂质,从中提取高纯度的fluralaner难度较大,因此,如何分离与fluralaner极性极为接近的杂质,获得高纯度的化合物氟雷拉纳,满足科研及其他如检测检验等方面的需要是目前存在的亟待解决的问题。Bravecto is a new drug with complex ingredients. The content of fluralaner is only 14%. Through HPLC-TOF-MS detection, it is found that there are impurities that are very close to the polarity of fluralaner. It is difficult to extract high-purity fluralaner from it. Therefore, how to Separation of impurities that are extremely close in polarity to fluralaner to obtain high-purity compound fluralaner to meet the needs of scientific research and other aspects such as detection and testing is an urgent problem to be solved at present.
发明内容Contents of the invention
本发明的目的主要在于提供一种从Bravecto中简便、高效地提取其有效活性成分氟雷拉纳单体化合物的方法。该方法可以成功从Bravecto中提取得到高纯度的氟雷拉纳化合物,满足对该化合物的需求问题或检测检验等问题。The purpose of the present invention is mainly to provide a method for easily and efficiently extracting the monomeric compound of the effective active ingredient Frellana from Bravecto. This method can successfully extract the high-purity Frellana compound from Bravecto, which meets the demand for the compound or the detection and inspection problems.
本发明提供的氟雷拉纳单体化合物的提取和纯化方法,包括如下步骤:The extraction and purification method of the Frellaner monomer compound provided by the invention comprises the following steps:
1)Bravecto制剂粉碎成粉末后,依次用石油醚、二氯甲烷、甲醇进行索式提取直至回流液澄清,将二氯甲烷提取液或三种提取液分别低压旋转蒸发得到粗提物;1) After the Bravecto preparation is pulverized into powder, Soxhlet extraction is performed sequentially with petroleum ether, dichloromethane, and methanol until the reflux liquid is clarified, and the dichloromethane extract or the three extracts are respectively evaporated at low pressure to obtain a crude extract;
2)称取与粗提物等质量的硅胶,石油醚溶解后倒入层析柱,待硅胶完全沉淀后测量硅胶在层析柱内的高度,记为1个高度单位,再向层析柱内加入6~8个高度单位的硅胶;2) Weigh the silica gel with the same quality as the crude extract, dissolve petroleum ether and pour it into the chromatography column. After the silica gel is completely precipitated, measure the height of the silica gel in the chromatography column, record it as 1 height unit, and then pour it into the chromatography column Add 6 to 8 height units of silica gel;
3)将步骤1)获得的粗提物加入层析柱内;3) adding the crude extract obtained in step 1) into the chromatographic column;
4)依次用体积比为(7.8~8.2):1、(5.8~6.2):1、(3.8~4.2):1、(2.8~3.2):1、(1.8~2.2):1、(0.8~1.2):1、2:(2.8~3.2)的石油醚-乙酸乙酯混合溶液进行层析分离,得到目标产物。4) The volume ratios are (7.8~8.2): 1, (5.8~6.2): 1, (3.8~4.2): 1, (2.8~3.2): 1, (1.8~2.2): 1, (0.8~ 1.2): 1, 2: (2.8~3.2) The petroleum ether-ethyl acetate mixed solution is subjected to chromatographic separation to obtain the target product.
本发明步骤1)中必须依次选用石油醚、二氯甲烷、甲醇进行索式提取,采用其他溶剂和不同提取顺序进行索氏提取则不能达到较完全的提取效果,且难以将其中性质相似的杂质分离。发明人经HPLC-TOF-MS检测,本发明中,石油醚进行索氏提取可将Bravecto中大部分的杂质,包括极性相近的杂质及少量fluralaner提取出来,然后用二氯甲烷进行索氏提取可将Bravecto中少量的不包括极性相近的杂质及大部分的fluralaner提取出来,最后用甲醇进行索氏提取可将Bravecto中剩余的fluralaner及少量的杂质提取出来。In step 1) of the present invention, sherwood oil, dichloromethane, and methanol must be selected successively for Soxhlet extraction. Using other solvents and different extraction sequences to carry out Soxhlet extraction can not achieve a more complete extraction effect, and it is difficult to remove impurities with similar properties. separate. The inventor detected by HPLC-TOF-MS. In the present invention, most of the impurities in Bravecto, including impurities with similar polarity and a small amount of fluralaner, can be extracted by Soxhlet extraction of petroleum ether, and then Soxhlet extraction is performed with dichloromethane A small amount of impurities that do not include similar polarities and most of the fluralaner in Bravecto can be extracted. Finally, Soxhlet extraction with methanol can extract the remaining fluralaner and a small amount of impurities in Bravecto.
优选的,本发明步骤1)索式提取过程中,石油醚提取温度为85~90℃;二氯甲烷提取温度为59~64℃;甲醇提取温度为87~93℃。如果低于上述温度范围则提取液无法进行提取,如果高于上述温度范围会导致提取液挥发,造成浪费,或提取液从冷凝管中大量溢出,造成一定危险和浪费。优选石油醚提取温度为88℃,二氯甲烷提取温度为61℃,甲醇提取温度为90℃。Preferably, in step 1) of the Soxhlet extraction process in the present invention, the extraction temperature of petroleum ether is 85-90°C; the extraction temperature of dichloromethane is 59-64°C; and the extraction temperature of methanol is 87-93°C. If it is lower than the above temperature range, the extract cannot be extracted. If it is higher than the above temperature range, the extract will volatilize and cause waste, or the extract will overflow from the condenser tube in large quantities, causing certain danger and waste. Preferably, the extraction temperature of petroleum ether is 88°C, the extraction temperature of dichloromethane is 61°C, and the extraction temperature of methanol is 90°C.
本发明步骤2)中,选用7~9个高度单位的硅胶,层析得到的fluralaner纯度最高,杂质含量最少。如果改变硅胶的量,则层析得到的fluralaner纯度会降低,且使用石油醚-乙酸乙酯混合溶液冲洗的效率会降低。优选的,选用8个高度单位的硅胶。In step 2) of the present invention, silica gel with 7 to 9 height units is selected, and the fluralaner obtained by chromatography has the highest purity and the least impurity content. If the amount of silica gel is changed, the purity of the fluralaner obtained by chromatography will decrease, and the efficiency of washing with petroleum ether-ethyl acetate mixed solution will decrease. Preferably, silica gel with 8 height units is selected.
本发明步骤3)优选的具体操作方式为:将步骤1)获得的粗提物加入二氯甲烷溶解,再加入与粗提物等质量的硅胶,干燥研磨成粉末状,缓慢加入层析柱内。本发明将步骤1)获得的粗提物加入二氯甲烷溶解,再加入与粗提物等质量的硅胶,可以使硅胶和粗提物混合的更加均匀,同时使硅胶和粗提物结合,这样后续在进行层析时极性相近的物质才会随缓冲液一起层析,从而将氟雷拉纳和其他杂质在不同比例的缓冲液冲洗中分离出来。The preferred specific operation mode of step 3) of the present invention is: add the crude extract obtained in step 1) into dichloromethane to dissolve, then add silica gel with the same quality as the crude extract, dry and grind it into powder, and slowly add it to the chromatography column . In the present invention, the crude extract obtained in step 1) is added into dichloromethane to dissolve, and then silica gel with the same quality as the crude extract is added, so that the silica gel and the crude extract can be mixed more uniformly, and the silica gel and the crude extract are combined at the same time, so that Subsequent chromatographic substances with similar polarity will be chromatographed together with the buffer, so that Frellana and other impurities can be separated in different proportions of buffer washing.
优选的,本发明步骤3)中干燥的温度为50~55℃。如果温度太低则无法通过加热蒸发的方式将液体去除;如果温度过高,则随着加热的进行,当表面皿中的物质趋于粘稠状时会大量溅出,造成药物的丢失,并具备一定的危险,如溅到皮肤上烫伤等。Preferably, the drying temperature in step 3) of the present invention is 50-55°C. If the temperature is too low, the liquid cannot be removed by heating and evaporating; if the temperature is too high, as the heating progresses, when the substance in the watch glass tends to be viscous, it will splash a lot, causing the loss of the drug, and Possess certain dangers, such as splashing on the skin and scalding.
优选的,本发明步骤4)中层析分离获得的含有目标产物的滤液,真空抽滤,烘干研磨即可得到目标产物。Preferably, the filtrate containing the target product obtained through chromatographic separation in step 4) of the present invention can be vacuum filtered, dried and ground to obtain the target product.
本发明所述的硅胶优选为100~200目。The silica gel described in the present invention is preferably 100-200 mesh.
为实现上述目的,本发明所采用的技术方案主要包括以下步骤:In order to achieve the above object, the technical solution adopted in the present invention mainly includes the following steps:
(1)将Bravecto用高速多功能粉碎机粉碎,用石油醚在88℃水浴条件下索氏提取直至石油醚提取回流液澄清为止;药粉继续使用二氯甲烷在61℃水浴条件下索氏提取,直至二氯甲烷提取回流液澄清为止;药粉继续使用甲醇在90℃水浴条件下索氏提取,直至甲醇提取回流液澄清为止;(1) Pulverize Bravecto with a high-speed multifunctional pulverizer, extract it with petroleum ether in a water bath at 88°C until the petroleum ether extraction reflux liquid is clarified; continue to use dichloromethane for Soxhlet extraction in a water bath at 61°C, Until the dichloromethane extraction reflux is clarified; the medicinal powder continues to use methanol for Soxhlet extraction in a water bath at 90°C until the methanol extraction reflux is clarified;
(2)分别将二氯甲烷或二氯甲烷、石油醚、甲醇的提取物分别在旋转蒸发仪上低压旋转蒸干,得到旋转蒸干后物质的质量;(2) Dichloromethane or the extracts of dichloromethane, sherwood oil, and methanol are respectively evaporated to dryness at low pressure on a rotary evaporator to obtain the quality of the substance after rotary evaporation;
(3)称取与蒸干物质等质量100~200目的硅胶,用石油醚溶解后倒入层析柱中,待硅胶完全沉淀后用刻度尺测量硅胶在层析柱内的高度,记为1个高度单位,再向层析柱内加入7个高度单位的硅胶;(3) Weigh 100-200 mesh silica gel with the same quality as the evaporated dry matter, dissolve it with petroleum ether and pour it into the chromatography column. After the silica gel is completely precipitated, use a scale to measure the height of the silica gel in the chromatography column, and record it as 1 height units, and then add 7 height units of silica gel to the chromatographic column;
(4)将旋转蒸干后的物质加入适量二氯甲烷,使其在烧瓶内完全溶解,倒入蒸发皿内,加入等质量的硅胶,在50~55℃的水浴锅上加热蒸干至研钵内完全干燥,然后充分研磨,使其完全变成粉末状,缓慢加入层析柱内;(4) Add an appropriate amount of dichloromethane to the material after rotary evaporation to make it completely dissolve in the flask, pour it into an evaporating dish, add silica gel of equal mass, and heat and evaporate to dryness in a water bath at 50-55°C until ground Completely dry in the bowl, then fully grind to make it completely powdery, slowly add to the chromatography column;
(5)配制体积比为8:1的石油醚-乙酸乙酯混合溶液进行分离,将层析柱内滤下的液体旋转蒸干,然后用该溶液溶解,点板后在紫外分析仪中检测并与标准品比对,层析一直进行到旋转蒸发后不再有固体物质析出;(5) Prepare a petroleum ether-ethyl acetate mixed solution with a volume ratio of 8:1 for separation, rotate the liquid filtered in the chromatography column to dryness, then dissolve it with the solution, and detect it in an ultraviolet analyzer after spotting the plate And compared with the standard product, the chromatography has been carried out until no solid matter is precipitated after rotary evaporation;
(6)分别配制6:1、4:1、3:1、2:1、1:1、2:3石油醚-乙酸乙酯混合溶液,依次加入层析柱内进行冲洗;将层析柱内滤下的液体低压旋转蒸干,然后用相应的混合溶液溶解,点板后在紫外分析仪中检测并与标准品比对;层析一直进行到旋转蒸发不再有固体物质析出,然后更换下一梯度溶液层析;(6) Prepare 6:1, 4:1, 3:1, 2:1, 1:1, 2:3 petroleum ether-ethyl acetate mixed solutions respectively, and add them to the chromatography column for washing; The liquid under the internal filter is evaporated to dryness under low pressure, and then dissolved with the corresponding mixed solution. After spotting the plate, it is detected in the ultraviolet analyzer and compared with the standard; the chromatography has been carried out until the rotary evaporation no longer has solid substances precipitated, and then replaced Next gradient solution chromatography;
(7)将层析得到的目的产物倒入玻璃抽滤漏斗进行真空抽滤,将得到的产物倒入玻璃培养皿内,烘干0.5-1.5h后研磨成粉末。(7) Pour the target product obtained by chromatography into a glass suction filter funnel for vacuum filtration, pour the obtained product into a glass petri dish, dry it for 0.5-1.5 h, and grind it into powder.
本发明的产物可以通过HPLC-TOF-MS进行检测,从而确定其纯度。The product of the present invention can be detected by HPLC-TOF-MS, so as to determine its purity.
本发明首次从Bravecto中提取出高纯度的氟雷拉纳化合物,方法简便快捷,具有较强的实用价值和现实意义。相对于现有技术,具有如下优势:The invention extracts the high-purity Frellana compound from Bravecto for the first time, and the method is simple and fast, and has strong practical value and practical significance. Compared with the prior art, it has the following advantages:
1)基于索式提取、低压旋转蒸发、层析柱分离等简单的化合物提取方法,可以简便、快速的提取Bravecto中的有效活性成分氟雷拉纳化合物;提取过程只需索式提取、旋转蒸发、层析柱分离、真空抽滤、HPLC-TOF-MS检测等操作,简便快捷;1) Based on simple compound extraction methods such as Soxhlet extraction, low-pressure rotary evaporation, and chromatographic column separation, the effective active ingredient Frellana compound in Bravecto can be easily and quickly extracted; the extraction process only requires Soxhlet extraction, rotary evaporation, Chromatographic column separation, vacuum filtration, HPLC-TOF-MS detection and other operations are simple and fast;
2)选用石油醚-乙酸乙酯混合溶液进行层析柱过滤,使用溶剂少,重复利用率高,高效节约;此外,真空抽滤操作简单,纯化效果好,得到的化合物纯度高;2) The petroleum ether-ethyl acetate mixed solution is selected for chromatographic column filtration, which uses less solvent, has a high reuse rate, and is highly efficient and economical; in addition, the vacuum filtration operation is simple, the purification effect is good, and the obtained compound is high in purity;
3)本发明按照石油醚、二氯甲烷、甲醇的顺序依次进行索氏提取:用石油醚进行索氏提取可将Bravecto中大部分的杂质,包括极性相近的杂质及少量fluralaner提取出来,然后用二氯甲烷进行索氏提取可将Bravecto中少量无极性相近的杂质及大部分的fluralaner提取出来,最后用甲醇进行索氏提取可将Bravecto中剩余的fluralaner及少量的杂质提取出来。采用其他溶剂和不同提取顺序进行所示提取则不能达到较完全的提取效果,且HPLC-TOF-MS检测发现不能将性质相似的杂质分离;3) The present invention carries out Soxhlet extraction sequentially according to the order of petroleum ether, dichloromethane and methanol: carrying out Soxhlet extraction with petroleum ether can extract most of the impurities in Bravecto, including impurities with similar polarity and a small amount of fluralaner, and then Soxhlet extraction with dichloromethane can extract a small amount of non-polar impurities and most of the fluralaner in Bravecto, and finally Soxhlet extraction with methanol can extract the remaining fluralaner and a small amount of impurities in Bravecto. Using other solvents and different extraction sequences to carry out the extraction shown can not achieve a more complete extraction effect, and HPLC-TOF-MS detection found that the impurities with similar properties cannot be separated;
4)本发明所述方法仅仅二氯甲烷索氏提取部分进一步提取纯化得到的氟雷拉纳单体化合物在质谱下检测纯度可达90%以上,液相色谱检测纯度高达100%,提取率在60%~70%;若加上石油醚和甲醇索氏提取的部分,提取率可以达到80%左右。4) In the method of the present invention, only the dichloromethane Soxhlet extraction part is further extracted and purified. The detection purity of the Frellana monomer compound obtained by mass spectrometry can reach more than 90%, and the detection purity by liquid chromatography is as high as 100%. 60% to 70%; if adding petroleum ether and methanol Soxhlet extraction, the extraction rate can reach about 80%.
5)本发明提取的目的物对德国小蠊、二化螟等卫生害虫和农业害虫具有优异的触杀活性。5) The target object extracted by the present invention has excellent contact killing activity to sanitary pests and agricultural pests such as German cockroach and Chilo borer.
附图说明Description of drawings
图1:层析液真空旋转蒸发后用紫外分析仪(254nm)比对图;Figure 1: Comparison chart with UV analyzer (254nm) after vacuum rotary evaporation of chromatography solution;
图2:HPLC-TOF-MS检测氟雷拉纳化合物质谱图谱;Figure 2: The mass spectrogram of the Frelaner compound detected by HPLC-TOF-MS;
图3:检测氟雷拉纳化合物液相色谱图谱;Figure 3: The liquid chromatogram for the detection of Frellaner compounds;
图4:检测氟雷拉纳化合物核质比图谱;Figure 4: The nucleomass ratio spectrum for the detection of Frellaner compounds;
图5:检测氟雷拉纳化合物紫外吸收峰图谱;Figure 5: Detection of the ultraviolet absorption peak spectrum of the Frelaner compound;
具体实施方式detailed description
为便于本领域技术人员对本发明的技术方案和有益效果进行理解,特结合附图对具体实施方式进行如下描述。应该指出,以下具体说明都是例示性的,旨在对本发明提供进一步的说明。除非另有说明,本发明使用的所有科学和技术术语具有与本发明所属技术领域人员通常理解的相同含义。In order to facilitate those skilled in the art to understand the technical solutions and beneficial effects of the present invention, specific implementation methods are described below in conjunction with the accompanying drawings. It should be pointed out that the following specific descriptions are all exemplary and are intended to provide further description of the present invention. Unless otherwise specified, all scientific and technical terms used in this invention have the same meaning as commonly understood by those skilled in the art to which this invention belongs.
实施例1:氟雷拉纳的提取和纯化Example 1: Extraction and Purification of Frellana
1.主要材料与试剂1. Main materials and reagents
点样毛细管(0.5×100)购自姜堰市康达实验器材厂;柱层析硅胶(精制型)购自青岛海洋化工厂分厂;层析柱购自东方科学仪器进出口集团有限公司。Bravecto购自德国默克公司;石油醚购自国药集团化学试剂有限公司;二氯甲烷、甲醇和乙酸乙酯购自广东光华科技股份有限公司。电热恒温鼓风干燥箱购自上海天恒医疗器械有限公司;高速多功能粉碎机购自德清拜杰电器有限公司;数显恒温水浴锅购自江苏省金坛市荣华仪器制造有限公司;索式提取器(150mL)和冷凝管(150mL)购自东方科学仪器进出口集团有限公司;ZF-20D暗箱式紫外分析仪和恒温水油浴锅购自巩义市予华仪器有限责任公司;架盘药物天平购自北京医用天平厂;旋转蒸发仪购自上海予英仪器有限公司;循环水式多用真空泵购自杭州大卫科教仪器有限公司;超声波破碎仪购自昆山市超声仪器有限公司。Spotting capillary (0.5×100) was purchased from Jiangyan Kangda Experimental Equipment Factory; column chromatography silica gel (refined type) was purchased from Qingdao Ocean Chemical Factory Branch; chromatography column was purchased from Dongfang Scientific Instruments Import and Export Group Co., Ltd. Bravecto was purchased from Merck, Germany; petroleum ether was purchased from Sinopharm Chemical Reagent Co., Ltd.; dichloromethane, methanol and ethyl acetate were purchased from Guangdong Guanghua Technology Co., Ltd. The electric heating and constant temperature blast drying oven was purchased from Shanghai Tianheng Medical Equipment Co., Ltd.; the high-speed multifunctional pulverizer was purchased from Deqing Baijie Electric Co., Ltd.; the digital display constant temperature water bath was purchased from Jintan Ronghua Instrument Manufacturing Co., Ltd., Jiangsu Province; Extractor (150mL) and condenser tube (150mL) were purchased from Dongfang Scientific Instrument Import and Export Group Co., Ltd.; ZF-20D dark box ultraviolet analyzer and constant temperature water and oil bath were purchased from Gongyi Yuhua Instrument Co., Ltd.; The balance was purchased from Beijing Medical Balance Factory; the rotary evaporator was purchased from Shanghai Yuying Instrument Co., Ltd.; the circulating water multi-purpose vacuum pump was purchased from Hangzhou David Science and Education Instrument Co., Ltd.; the ultrasonic breaker was purchased from Kunshan Ultrasonic Instrument Co., Ltd.
2.实验步骤2. Experimental steps
(1)取30g Bravecto片剂,用高速多功能粉碎机将其粉碎成粉末状,用石油醚在88℃水浴条件下索氏提取直至石油醚提取液澄清为止;(1) Take 30g of Bravecto tablet, pulverize it into powder with a high-speed multifunctional pulverizer, and extract it with petroleum ether in a water bath at 88°C until the petroleum ether extract is clarified;
(2)粉末状药粉继续使用二氯甲烷在61℃水浴条件下索氏提取,直至二氯甲烷提取液澄清为止;(2) Continue to use dichloromethane for Soxhlet extraction of the powdered medicinal powder in a water bath at 61°C until the dichloromethane extract is clarified;
(3)粉末状药粉继续使用甲醇在90℃水浴条件下索氏提取,直至甲醇提取液澄清为止;(3) Continue to use methanol for Soxhlet extraction in a water bath at 90°C until the methanol extract is clarified;
(4)分别将石油醚、二氯甲烷、甲醇的粗提物在旋转蒸发仪上低压旋转蒸干(旋转蒸干过程中保持真空泵一直处于开启状态,油浴锅调制49℃,烧瓶部分浸入油浴锅的水内,并保持冷凝管处于通水状态)。用托盘天平称量蒸干后的物质质量,分别得到12.5g、10.25g、11.25g物质;(4) The crude extracts of petroleum ether, dichloromethane, and methanol were evaporated to dryness at low pressure on a rotary evaporator (the vacuum pump was kept on during the rotary evaporation process, the oil bath was adjusted to 49°C, and the flask was partially immersed in oil the water in the heating bath, and keep the condenser tube in the state of water). Weigh the mass of the material after evaporation with a tray balance, and obtain 12.5g, 10.25g, and 11.25g of the material respectively;
(5)选择合适长度的玻璃层析柱,关闭阀门后加入适量三氯甲烷,检测是否漏水,选取阀门密闭的层析柱;(5) Select a glass chromatography column with a suitable length, add an appropriate amount of chloroform after closing the valve, check whether there is water leakage, and select a chromatography column with a closed valve;
(6)称取10.25g(二氯甲烷部分物质)硅胶(100-200目),用石油醚溶解后倒入层析柱中,待硅胶完全沉淀后用刻度尺测量硅胶在层析柱内的高度,2.5cm,记为1个高度单位。用同样的方法再向层析柱内加入7个高度单位的硅胶,即17.5cm,层析柱内硅胶高度共计20cm;(6) Take by weighing 10.25g (dichloromethane partial substance) silica gel (100-200 mesh), pour in the chromatographic column after dissolving with sherwood oil, measure the silica gel in the chromatographic column with a scale after the silica gel is completely precipitated. The height, 2.5cm, is recorded as 1 height unit. Use the same method to add 7 height units of silica gel to the chromatography column, that is, 17.5cm, and the total height of silica gel in the chromatography column is 20cm;
(7)将旋转蒸干后的二氯甲烷部分物质加入适量二氯甲烷,使其在烧瓶内完全溶解,倒入研钵内,加入等质量的硅胶,在50-55℃的水浴锅上加热蒸干至研钵内完全干燥,然后充分研磨,使其完全变成粉末状;(7) Add an appropriate amount of dichloromethane to some of the dichloromethane after rotary evaporation to completely dissolve it in the flask, pour it into a mortar, add silica gel of equal mass, and heat it on a water bath at 50-55°C Evaporate until it is completely dry in the mortar, and then grind it sufficiently to make it completely powdery;
(8)将粉末状混合物缓慢倒入层析柱内,待其完全沉淀后,剪一张比层析柱内径略小的滤纸,放入层析柱内,使其平盖在混合物上层,然后向层析柱内塞入一团脱脂棉。打开层析柱阀门,将层析柱内的石油醚放掉大部分;(8) Slowly pour the powdered mixture into the chromatography column. After it is completely precipitated, cut a piece of filter paper slightly smaller than the inner diameter of the chromatography column, put it into the chromatography column, and make it flat on the upper layer of the mixture, and then Insert a ball of absorbent cotton into the column. Open the chromatographic column valve, let off most of the petroleum ether in the chromatographic column;
(9)配制石油醚-乙酸乙酯(8:1)混合溶液,加入层析柱内,开始冲洗(层析柱内必须始终保持有液体)。将层析柱内滤下的液体低压旋转蒸干,然后用该溶液溶解,点板后,在紫外分析仪内检测并与标准品比对(图1)。层析一直进行到旋转蒸发不再有固体物质析出;(9) Prepare a mixed solution of petroleum ether-ethyl acetate (8:1), add it to the chromatography column, and start washing (the liquid must always be kept in the chromatography column). The liquid filtered in the chromatography column was evaporated to dryness under low pressure, and then dissolved with the solution. After spotting the plate, it was detected in the ultraviolet analyzer and compared with the standard (Figure 1). Chromatography was carried out until no solid material was precipitated by rotary evaporation;
(10)分别配制6:1、4:1、3:1、2:1、1:1、2:3石油醚-乙酸乙酯混合溶液,依次加入层析柱内进行层析。将层析柱内滤下的液体旋转蒸干,然后用该溶液溶解,使用硅胶板G254点板后,在紫外分析仪254nm处检测并与标准品比对(图1)。层析一直进行到旋转蒸发不再有固体物质析出,然后更换下一梯度溶液冲洗;(10) Prepare 6:1, 4:1, 3:1, 2:1, 1:1, 2:3 petroleum ether-ethyl acetate mixed solutions respectively, and add them to the chromatography column for chromatography in sequence. The liquid filtered in the chromatography column was spun to dryness, then dissolved with the solution, spotted on a silica gel plate G254, detected at 254nm by an ultraviolet analyzer and compared with a standard (Figure 1). Chromatography has been carried out until no solid matter is precipitated by rotary evaporation, and then the next gradient solution is replaced for washing;
(11)将层析分离得到的目的产物倒入玻璃抽滤漏斗进行真空抽滤,将得到的产物倒入玻璃培养皿内,烘干后(0.5-1.5h)得到2.62g固体,即为氟雷拉纳化合物,即本发明的目的组分。(11) Pour the target product obtained from chromatographic separation into a glass suction filter funnel for vacuum filtration, pour the obtained product into a glass petri dish, and dry (0.5-1.5h) to obtain 2.62g of solid, which is fluorine The relana compound is the object component of the present invention.
通过该方法提取得到的氟雷拉纳化合物提取率为62.38%,经HPLC-TOF-MS检测其纯度>99%(图2~图5)。The extraction rate of the Frelaner compound extracted by this method is 62.38%, and its purity is >99% as detected by HPLC-TOF-MS (Fig. 2-Fig. 5).
实施例2:氟雷拉纳的提取和纯化Embodiment 2: Extraction and purification of Freilaner
1.所用的试验仪器与试剂准备与实例1基本相同;1. The test equipment used and the reagent preparation are basically the same as Example 1;
2.实验方法:2. Experimental method:
(1)取30g Bravecto片剂,用高速多功能粉碎机将其粉碎成粉末状,用石油醚在88℃水浴条件下索氏提取直至石油醚提取液澄清为止;(1) Take 30g of Bravecto tablet, pulverize it into powder with a high-speed multifunctional pulverizer, and extract it with petroleum ether in a water bath at 88°C until the petroleum ether extract is clarified;
(2)粉末状药粉继续使用二氯甲烷在61℃水浴条件下索氏提取,直至二氯甲烷提取液澄清为止;(2) Continue to use dichloromethane for Soxhlet extraction of the powdered medicinal powder in a water bath at 61°C until the dichloromethane extract is clarified;
(3)粉末状药粉继续使用甲醇在90℃水浴条件下索氏提取,直至甲醇提取液澄清为止;(3) Continue to use methanol for Soxhlet extraction in a water bath at 90°C until the methanol extract is clarified;
(4)分别将石油醚、二氯甲烷、甲醇的粗提物在旋转蒸发仪上低压旋转蒸干(旋转蒸干过程中保持真空泵一直处于开启状态,油浴锅调制49℃,烧瓶部分浸入油浴锅的水内,并保持冷凝管处于通水状态)。用托盘天平称量蒸干后的物质质量,分别得到12.5g、10.25g、11.25g物质;(4) The crude extracts of petroleum ether, dichloromethane, and methanol were evaporated to dryness at low pressure on a rotary evaporator (the vacuum pump was kept on during the rotary evaporation process, the oil bath was adjusted to 49°C, and the flask was partially immersed in oil the water in the heating bath, and keep the condenser tube in the state of water). Weigh the mass of the material after evaporation with a tray balance, and obtain 12.5g, 10.25g, and 11.25g of the material respectively;
(5)选择合适长度的玻璃层析柱,关闭阀门后加入适量三氯甲烷,检测是否漏水,选取阀门密闭的层析柱;(5) Select a glass chromatography column with a suitable length, add an appropriate amount of chloroform after closing the valve, check whether there is water leakage, and select a chromatography column with a closed valve;
(6)称取10.25g(二氯甲烷部分物质)硅胶(100-200目),用石油醚溶解后倒入层析柱中,待硅胶完全沉淀后用刻度尺测量硅胶在层析柱内的高度,2.5cm,记为1个高度单位。用同样的方法再向层析柱内加入7个高度单位的硅胶,即17.5cm,层析柱内硅胶高度共计20cm;(6) Take by weighing 10.25g (dichloromethane partial substance) silica gel (100-200 mesh), pour in the chromatographic column after dissolving with sherwood oil, measure the silica gel in the chromatographic column with a scale after the silica gel is completely precipitated. The height, 2.5cm, is recorded as 1 height unit. Use the same method to add 7 height units of silica gel to the chromatography column, that is, 17.5cm, and the total height of silica gel in the chromatography column is 20cm;
(7)将旋转蒸干后的二氯甲烷部分物质加入适量二氯甲烷,使其在烧瓶内完全溶解,倒入研钵内,加入等质量的硅胶,在50-55℃的水浴锅上加热蒸干至研钵内完全干燥,然后充分研磨,使其完全变成粉末状;(7) Add an appropriate amount of dichloromethane to some of the dichloromethane after rotary evaporation to completely dissolve it in the flask, pour it into a mortar, add silica gel of equal mass, and heat it on a water bath at 50-55°C Evaporate until it is completely dry in the mortar, and then grind it sufficiently to make it completely powdery;
(8)将粉末状混合物缓慢倒入层析柱内,待其完全沉淀后,剪一张比层析柱内径略小的滤纸,放入层析柱内,使其平盖在混合物上层,然后向层析柱内塞入一团脱脂棉。打开层析柱阀门,将层析柱内的石油醚放掉大部分;(8) Slowly pour the powdered mixture into the chromatography column. After it is completely precipitated, cut a piece of filter paper slightly smaller than the inner diameter of the chromatography column, put it into the chromatography column, and make it flat on the upper layer of the mixture, and then Insert a ball of absorbent cotton into the column. Open the chromatographic column valve, let off most of the petroleum ether in the chromatographic column;
(9)配制石油醚-乙酸乙酯(8:1)混合溶液,加入层析柱内,开始冲洗(层析柱内必须始终保持有液体)。将层析柱内滤下的液体低压旋转蒸干,然后用该溶液溶解,点板后,在紫外分析仪内检测并与标准品比对(图1)。层析一直进行到旋转蒸发不再有固体物质析出;(9) Prepare a mixed solution of petroleum ether-ethyl acetate (8:1), add it to the chromatography column, and start washing (the liquid must always be kept in the chromatography column). The liquid filtered in the chromatography column was evaporated to dryness under low pressure, and then dissolved with the solution. After spotting the plate, it was detected in the ultraviolet analyzer and compared with the standard (Figure 1). Chromatography was carried out until no solid material was precipitated by rotary evaporation;
(10)分别配制6:1、4:1、3:1、2:1、1:1、2:3石油醚-乙酸乙酯混合溶液,依次加入层析柱内进行层析。将层析柱内滤下的液体旋转蒸干,然后用该溶液溶解,点板后,在紫外分析仪内检测并与标准品比对。层析一直进行到旋转蒸发不再有固体物质析出,然后更换下一梯度溶液冲洗;(10) Prepare 6:1, 4:1, 3:1, 2:1, 1:1, 2:3 petroleum ether-ethyl acetate mixed solutions respectively, and add them to the chromatography column for chromatography in sequence. Rotate the liquid filtered in the chromatography column to dryness, then dissolve it with the solution, spot the plate, detect it in the ultraviolet analyzer and compare it with the standard. Chromatography has been carried out until no solid matter is precipitated by rotary evaporation, and then the next gradient solution is replaced for washing;
(11)采用(6)-(10)相同的方法来层析石油醚索式提取后得到的12.5g粗提物和甲醇索式提取后得到的11.25g粗提物,将层析分离得到的目的产物倒入玻璃抽滤漏斗进行真空抽滤,将得到的产物倒入玻璃培养皿内,烘干后(0.5-1.5h)得到3.15g固体,即为氟雷拉纳化合物,即本发明的目的组分。(11) Adopt (6)-(10) identical method to come the 12.5g crude extract that obtains after petroleum ether Soxhlet extraction and the 11.25g crude extract that obtain after methanol Soxhlet extraction, separate the chromatographically obtained Pour the target product into a glass suction filter funnel for vacuum filtration, pour the obtained product into a glass petri dish, and dry (0.5-1.5h) to obtain 3.15g of solid, which is the Freilaner compound, which is the compound of the present invention. target component.
通过该方法提取得到的氟雷拉纳化合物提取率为75.00%,纯度>85%,其中2.20g纯度>98%,0.82g纯度>91%,0.13g纯度>85%。The extraction rate of the Frelaner compound extracted by this method is 75.00%, and the purity is >85%, wherein 2.20g has a purity >98%, 0.82g has a purity >91%, and 0.13g has a purity >85%.
活性实验activity test
一、氟雷拉纳对德国小蠊的活性测定试验One, the activity determination test of Frellana to German cockroach
1.主要材料和试剂1. Main materials and reagents
德国小蠊(Blattella germanica)室内饲养品系,由本实验室(南京农业大学植物保护学院昆虫生理生化与分子生物学实验室)提供,在未接触任何杀虫剂的条件下用人工饲料连续饲养。氟虫腈(92%),丁烯氟虫腈(92%),敌敌畏(93%),均由本实验室提供;高效氯氰菊酯(93%),残杀威(>99%),胡椒基丁醚(95%),购自上海阿拉丁生化科技股份有限公司;丙酮,购自南京农业大学后勤集团公司。手动微量点滴器,购自Burkard公司;加湿器、一次性塑料杯、橡皮筋、棉花、凡士林、培养皿、方形塑料缸等,均购自南京寿德试验器材有限公司;面粉、奶粉、葡萄糖等,均购自超市。The German cockroach (Blattella germanica) indoor rearing strain was provided by our laboratory (Insect Physiology, Biochemistry and Molecular Biology Laboratory, School of Plant Protection, Nanjing Agricultural University), and was continuously reared with artificial diet without contacting any insecticides. Fipronil (92%), butene fipronil (92%), dichlorvos (93%), all provided by this laboratory; beta-cypermethrin (93%), propoxur (>99%), piperonyl butoxide ( 95%), purchased from Shanghai Aladdin Biochemical Technology Co., Ltd.; acetone, purchased from Nanjing Agricultural University Logistics Group Company. Manual micro-droppers were purchased from Burkard; humidifiers, disposable plastic cups, rubber bands, cotton, vaseline, Petri dishes, square plastic cylinders, etc. were purchased from Nanjing Shoude Experimental Equipment Co., Ltd.; flour, milk powder, glucose, etc. , were purchased from supermarkets.
饲养方法:在室内饲养缸中以不分龄期的方式混合饲养,饲养缸口内壁1/3深处涂3-5cm宽的凡士林油带,以防逃逸。饲养缸内放置两个培养皿,一个培养皿用于盛放混合饲料(面粉:奶粉:葡萄糖比例为6:3:1混合),另一个培养皿用于盛放含水和棉花,每3-4天补充饲料和水。分离缸底部放入多层折叠硬纸板,作为德国小蠊的栖息场所;饲养缸用单层纱布封住,以防逃逸。定期打扫饲养缸,保持洁净的饲养环境。适时观察德国小蠊的密度,0.6-1.0只/cm2为宜,既保证虫体的正常发育,又充分利用饲养缸饲养最大量的试虫,当密度高于该范围时,应分缸饲养。养殖条件为温度(26±1)℃,湿度(60±5)%,光照条件(L:D为16:8h)。Breeding method: Mixed breeding in an indoor breeding tank regardless of age, 1/3 of the inner wall of the feeding tank mouth is coated with a 3-5cm wide Vaseline oil band to prevent escape. Place two petri dishes in the rearing tank, one petri dish is used to hold the mixed feed (flour:milk powder:glucose ratio is 6:3:1 mixed), the other petri dish is used to hold water and cotton, every 3-4 Feed and water were supplemented daily. Put multi-layer folded cardboard into the bottom of the separation cylinder as the habitat of Blattella germanica; the rearing cylinder is sealed with a single layer of gauze to prevent escape. Clean the breeding tank regularly to maintain a clean breeding environment. Observe the density of Blattella germanica in good time, 0.6-1.0/ cm2 is appropriate, which not only ensures the normal development of the insect body, but also makes full use of the rearing tank to raise the largest number of test insects. When the density is higher than this range, it should be reared in separate tanks . The breeding conditions are temperature (26±1)°C, humidity (60±5)%, light conditions (L:D is 16:8h).
2.药物配制2. Drug preparation
2.1氟雷拉纳溶液的配制2.1 Preparation of Frellana solution
以丙酮为溶剂配制10,000mg/L的氟雷拉纳母液,再用丙酮稀释至1.25mg/L、2.5mg/L、5.0mg/L、7.5mg/L、10.0mg/L、12.5mg/L六个浓度梯度。Prepare a 10,000mg/L stock solution of Frellana with acetone as a solvent, then dilute to 1.25mg/L, 2.5mg/L, 5.0mg/L, 7.5mg/L, 10.0mg/L, 12.5mg/L with acetone Six concentration gradients.
2.2常用杀虫剂溶液的配制2.2 Preparation of commonly used pesticide solutions
以丙酮为溶剂配制10,000mg/L的氟虫腈、丁烯氟虫腈、敌敌畏、高效氯氢菊酯、残杀威母液,再用丙酮将各药剂分别稀释至5.0mg/L。Prepare 10,000mg/L mother liquors of fipronil, butylene-fipronil, dichlorvos, beta-permethrin, and propoxur with acetone as a solvent, and then dilute each agent to 5.0mg/L with acetone.
3.点滴法测定氟雷拉纳及常用杀虫剂对德国小蠊的活性3. Determination of the activity of Frellana and commonly used insecticides against German cockroaches by spot method
选取德国小蠊雄性成虫30头,随机分成3组,每组10头。将试虫用CO2麻醉后,仰卧排列在培养皿内,用手动微量点滴器依次按低至高浓度(0.16mg/L、0.80mg/L、4.0mg/L、20.0mg/L、100.0mg/L)的氟雷拉纳将1.0μL药液点滴在试虫第2、第3对足基节间的腹板上,然后转入清洁的容器中,用混合饲料和浸水棉球正常喂养。设丙酮做空白对照,于24h、48h、72h、96h、120h后检查死亡率。以虫体仰翻、不能爬行为死亡标准。30 male adults of Blattella germanica were selected and randomly divided into 3 groups with 10 adults in each group. After the test insects were anesthetized with CO 2 , they were arranged on their backs in a petri dish, and were sequentially adjusted from low to high concentrations (0.16mg/L, 0.80mg/L, 4.0mg/L, 20.0mg/L, 100.0mg/L) with a manual micro-dropper. L) Freilaner. Drop 1.0 μL of the drug solution on the web between the second and third pair of foot bases of the test insect, then transfer it to a clean container, and feed it with mixed feed and water-soaked cotton balls. Acetone was set as a blank control, and the mortality rate was checked after 24h, 48h, 72h, 96h, and 120h. The standard of death is to turn the worm body upside down and not to crawl.
用丙酮将药剂稀释为不同浓度梯度的药液以备用。将试虫用CO2麻醉,由低至高浓度依次用手动微量点滴器将1.0μL药液点滴在试虫第2、第3对足基节间的腹板上。每个浓度级各滴10只,重复3次。以丙酮作为空白对照。点药后置于内含饲料和含水棉花的一次性塑料杯中正常饲养,杯口用单层纱布封住,以防逃逸。于24h、48h、72h、96h、120h后检查死亡率。以虫体仰翻、不能爬行为死亡标准。每种药剂均作3次以上重复。Use acetone to dilute the medicine into medicine solutions with different concentration gradients for future use. The test insects were anesthetized with CO 2 , and 1.0 μL of the drug solution was dripped on the web between the second and third pair of foot bases of the test insects with a manual micro-dropper in order from low to high concentrations. 10 rats were dropped in each concentration level, and repeated 3 times. Acetone was used as blank control. After the medicine is dispensed, they are placed in disposable plastic cups containing feed and water-containing cotton for normal feeding, and the mouth of the cup is sealed with a single layer of gauze to prevent escape. Mortality was checked after 24h, 48h, 72h, 96h, and 120h. The standard of death is to turn the worm body upside down and not to crawl. Each drug was repeated more than 3 times.
4.数据统计分析4. Statistical analysis of data
利用POLO Plus、SPSS 17.0等软件,求出毒力回归方程y=a+bx、LC50、LD50等。各实验数据如表-1和表-2。Use POLO Plus, SPSS 17.0 and other software to obtain the regression equation of virulence y=a+bx, LC50, LD50, etc. The experimental data are shown in Table-1 and Table-2.
表-1氟雷拉纳对德国小蠊的毒力测定试验结果Table-1 Freilaner is to the virulence determination test result of German cockroach
表-2氟雷拉纳及六种常用药剂对德国小蠊的敏感性测定试验结果Table-2 Freilaner and six commonly used medicaments to the sensitivity test results of German cockroaches
注:*表示显著差异,**表示达到极显著差异。Note: * indicates significant difference, ** indicates extremely significant difference.
由以上数据可知,氟雷拉纳对德国小蠊在24h、48h、72h、96h、120h的LD50值分别为0.0117、0.0076、0.0066、0.0046和0.0045μg/头。由此可见氟雷拉纳对德国小蠊的毒力作用在0-96h内随时间增加而增大,而96h后毒力作用趋于稳定。使用SPSS 17.0软件对几种常规药剂与氟雷拉纳的毒力进行差异显著性分析,结果显示5mg/L的丁烯氟虫腈、氟虫腈、敌敌畏、氟雷拉纳、高效氯氢菊酯、残杀威六种药剂对德国小蠊的致死率分别为80.00%、80.00%、58.89%、51.11%、42.22%、21.11%。由表2可见,氟虫腈、丁烯氟虫腈杀虫活性相对较好,高于氟雷拉纳;敌敌畏、氟雷拉纳、高效氯氢菊酯次之,三者的杀虫活性无显著差异;残杀威的杀虫活性相对最差,并极显著低于氟雷拉纳。From the above data, it can be known that the LD 50 values of Freilaner against Blattella germanica at 24h, 48h, 72h, 96h, and 120h were 0.0117, 0.0076, 0.0066, 0.0046, and 0.0045 μg/head, respectively. It can be seen that the virulence of Freilaner to the German cockroach increases with time in 0-96h, and the virulence after 96h tends to be stable. SPSS 17.0 software was used to analyze the significant difference between the toxicity of several conventional agents and Frellaner, and the results showed that 5mg/L butene fipronil, fipronil, dichlorvos, Frellaner, and beta-permethrin The lethality rates of esters and propoxur against German cockroaches were 80.00%, 80.00%, 58.89%, 51.11%, 42.22%, and 21.11%, respectively. It can be seen from Table 2 that the insecticidal activity of fipronil and butylene-fipronil is relatively good, higher than that of Freylana; followed by Dichlorvos, Freylana, and Beta-Permethrin, and the insecticidal activity of the three has no Significant difference; the insecticidal activity of propoxur was relatively the worst, and it was significantly lower than that of Frellana.
二、氟雷拉纳对二化螟的室内活力测定试验2. Indoor viability test of Freilaner against Chilo suppressalis
1主要材料与试剂1 Main materials and reagents
室内饲养的二化螟(Chilo suppressalis)品系,选用同一世代的4龄幼虫(9.00-11.00mg/头),由南京农业大学植物保护学院昆虫生理生化与分子生物学实验室提供。氟虫腈(92%),由南京农业大学植物保护学院昆虫生理生化与分子生物学实验室提供。For the strain of Chilo suppressalis grown indoors, 4th instar larvae of the same generation (9.00-11.00 mg/head) were selected from the Laboratory of Insect Physiology, Biochemistry and Molecular Biology, School of Plant Protection, Nanjing Agricultural University. Fipronil (92%) was provided by the Laboratory of Insect Physiology, Biochemistry and Molecular Biology, School of Plant Protection, Nanjing Agricultural University.
2毒力测定方法2 Toxicity determination method
毒力测定方法参照《水稻二化螟抗药性监测技术规程毛细管滴定法》(NY/T 2058-2011),加以改进,适用于二化螟4龄幼虫的毒力测定。在电子天平上称取原药,使用丙酮溶解,配制成一定浓度的母液。将溶解后的母液分装于2mL离心管中,冷储于-20℃。用移液枪吸取一定量的母液,用丙酮等比稀释成6-7个浓度备用,以丙酮作为对照,每管不少于2mL。The virulence determination method was improved by referring to the Capillary Titration Method of Technical Regulations for Monitoring the Resistance of Rice Chipotle Borer (NY/T 2058-2011), and it was suitable for the virulence determination of the 4th instar larvae of Chilo suppressalis. The original drug was weighed on an electronic balance, dissolved in acetone, and prepared into a mother liquor with a certain concentration. The dissolved mother liquor was divided into 2mL centrifuge tubes and stored at -20°C. Take a certain amount of mother liquor with a pipette, dilute it with acetone to 6-7 concentrations for later use, use acetone as a control, and each tube should not be less than 2mL.
挑取9.00-11.00mg的二化螟4龄幼虫,按照供试药液浓度由低到高的顺序处理。用微量点滴器吸取药液点滴于试虫中胸部背面,每头试虫点滴1μL,每个浓度处理30头。将点滴后的试虫置于种有水稻种苗的平底大试管中,每个试管放置10头,设3次重复,对照组点滴等体积丙酮。将处理后的试虫放回原饲养环境中,于24h和48h时观察幼虫存活情况,以毛笔轻触虫体,虫体不能协调运动为死亡标准,记录死亡数。Pick 9.00-11.00 mg of the 4th instar larvae of Chilo borer, and treat them according to the order of concentration of the test solution from low to high. Use a micro-dropper to draw the drug solution and drop it on the back of the chest of the test insects, drip 1 μL per test insect, and treat 30 insects at each concentration. Place the test insects after spotting in a large flat-bottomed test tube planted with rice seedlings, 10 in each test tube, and set 3 repetitions. The control group was dripped with an equal volume of acetone. Put the treated test worms back into the original breeding environment, observe the survival of the larvae at 24h and 48h, lightly touch the larvae with a brush, and the worms cannot coordinate movement as the death standard, and record the number of deaths.
3数据统计分析3 Statistical analysis of data
采用POLO PLUS(LeOra Software,2003)软件计算毒力回归方程。计算参数包括b值、LC50及其95%置信限。各实验数据如表-3。The virulence regression equation was calculated using POLO PLUS (LeOra Software, 2003) software. Calculation parameters include b value, LC 50 and its 95% confidence limit. The experimental data are shown in Table-3.
表-3氟雷拉纳对室内二化螟品系的毒力测定结果Table-3 Toxicity test results of Freilaner to indoor Chilo borer strains
由以上数据可以看出,采用点滴法测定氟雷拉纳和氟虫腈对室内饲养的二化螟品系的活性,结果表明:氟雷拉纳处理24h和48h的LD50值分别为0.022和0.003μg/头。氟虫腈处理24h和48h的LD50值分别为0.025和0.004μg/头。It can be seen from the above data that the spot method was used to measure the activity of Freylana and fipronil on the strains of Chilo borer reared indoors. The results showed that the LD50 values of Freylana for 24h and 48h were 0.022 and 0.003 respectively. μg/head. The LD 50 values of fipronil treated for 24h and 48h were 0.025 and 0.004μg/head, respectively.
由此可知,在处理48h后,氟雷拉纳和氟虫腈对二化螟4龄幼虫的毒杀作用均明显大于24h。处理48h后,氟雷拉纳和氟虫腈对二化螟的LD50值分别为0.003和0.004μg/头,说明氟雷拉纳对二化螟4龄幼虫的活性大于氟虫腈,具有良好的杀虫效果。It can be seen that after 48 hours of treatment, the poisonous effects of Freilaner and fipronil on the 4th instar larvae of Chilo borer were significantly greater than 24 hours. After 48 hours of treatment, the LD 50 values of Freilaner and Fipronil against C. borer were 0.003 and 0.004 μg/head, respectively, indicating that the activity of Freilaner against the 4th instar larvae of C. insecticidal effect.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710701591.9A CN107501199A (en) | 2017-08-16 | 2017-08-16 | The extraction of fluorine thunder Rana monomeric compound and purification process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710701591.9A CN107501199A (en) | 2017-08-16 | 2017-08-16 | The extraction of fluorine thunder Rana monomeric compound and purification process |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107501199A true CN107501199A (en) | 2017-12-22 |
Family
ID=60691937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710701591.9A Pending CN107501199A (en) | 2017-08-16 | 2017-08-16 | The extraction of fluorine thunder Rana monomeric compound and purification process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107501199A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110596268A (en) * | 2019-09-20 | 2019-12-20 | 天津市中升挑战生物科技有限公司 | Separation and detection method for isomers in loratadine racemate |
CN111308002A (en) * | 2020-02-24 | 2020-06-19 | 丽珠集团新北江制药股份有限公司 | Method for detecting isoxazoline insecticide and impurities thereof |
CN113009048A (en) * | 2021-04-16 | 2021-06-22 | 成都海关技术中心 | Method for detecting content of flurarana by using dispersed solid phase extraction and liquid chromatography tandem mass spectrometry |
CN113030345A (en) * | 2021-04-16 | 2021-06-25 | 成都海关技术中心 | Method for determining residual frainer in animal derived food and application |
CN113121383A (en) * | 2021-04-22 | 2021-07-16 | 江苏慧聚药业有限公司 | Related substances of Aforana and frailana synthesized building blocks and synthesis method thereof |
CN113759052A (en) * | 2021-09-07 | 2021-12-07 | 丽珠集团新北江制药股份有限公司 | Method for detecting related substances in frataxin initiator |
CN113773269A (en) * | 2020-06-09 | 2021-12-10 | 海门慧聚药业有限公司 | Crystal form of Florana and preparation method thereof |
CN114113390A (en) * | 2021-11-24 | 2022-03-01 | 丽珠集团新北江制药股份有限公司 | Method for detecting flurarana intermediate and impurities thereof |
CN116217509A (en) * | 2023-03-16 | 2023-06-06 | 艾美科健(中国)生物医药有限公司 | A related substance of Frellaner and its preparation method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102149695A (en) * | 2008-07-09 | 2011-08-10 | 日产化学工业株式会社 | Process for production of isoxazoline-substituted benzoic acid amide compound |
CN106999475A (en) * | 2014-12-22 | 2017-08-01 | 英特维特国际股份有限公司 | Isoxazoline compounds are used for the purposes for treating demodicidosis |
-
2017
- 2017-08-16 CN CN201710701591.9A patent/CN107501199A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102149695A (en) * | 2008-07-09 | 2011-08-10 | 日产化学工业株式会社 | Process for production of isoxazoline-substituted benzoic acid amide compound |
CN106999475A (en) * | 2014-12-22 | 2017-08-01 | 英特维特国际股份有限公司 | Isoxazoline compounds are used for the purposes for treating demodicidosis |
Non-Patent Citations (3)
Title |
---|
李丽洁 主编: "《含氮化合物制备与表征实验》", 31 August 2015, 北京航空航天大学出版社 * |
李映苓 主编: "《有机化学实验》", 31 July 2008, 云南大学出版社 * |
赵春青 等: "杀虫剂fluralaner 及其衍生物的生物效应和毒理学研究进展", 《农药学学报》 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110596268B (en) * | 2019-09-20 | 2022-04-26 | 天津市中升挑战生物科技有限公司 | Separation and detection method for isomers in loratadine racemate |
CN110596268A (en) * | 2019-09-20 | 2019-12-20 | 天津市中升挑战生物科技有限公司 | Separation and detection method for isomers in loratadine racemate |
CN111308002A (en) * | 2020-02-24 | 2020-06-19 | 丽珠集团新北江制药股份有限公司 | Method for detecting isoxazoline insecticide and impurities thereof |
CN113773269A (en) * | 2020-06-09 | 2021-12-10 | 海门慧聚药业有限公司 | Crystal form of Florana and preparation method thereof |
CN113030345A (en) * | 2021-04-16 | 2021-06-25 | 成都海关技术中心 | Method for determining residual frainer in animal derived food and application |
CN113009048A (en) * | 2021-04-16 | 2021-06-22 | 成都海关技术中心 | Method for detecting content of flurarana by using dispersed solid phase extraction and liquid chromatography tandem mass spectrometry |
CN113030345B (en) * | 2021-04-16 | 2023-10-13 | 成都海关技术中心 | Determination method and application of fluorine Lei Lana residues in animal-derived food |
CN113009048B (en) * | 2021-04-16 | 2023-10-13 | 成都海关技术中心 | Method for detecting content of fluororalrana by dispersive solid-phase extraction and liquid chromatography tandem mass spectrometry |
CN113121383A (en) * | 2021-04-22 | 2021-07-16 | 江苏慧聚药业有限公司 | Related substances of Aforana and frailana synthesized building blocks and synthesis method thereof |
CN113759052A (en) * | 2021-09-07 | 2021-12-07 | 丽珠集团新北江制药股份有限公司 | Method for detecting related substances in frataxin initiator |
CN113759052B (en) * | 2021-09-07 | 2023-05-23 | 丽珠集团新北江制药股份有限公司 | Method for detecting related substances in fluorine Lei Lana initiator |
CN114113390A (en) * | 2021-11-24 | 2022-03-01 | 丽珠集团新北江制药股份有限公司 | Method for detecting flurarana intermediate and impurities thereof |
CN116217509A (en) * | 2023-03-16 | 2023-06-06 | 艾美科健(中国)生物医药有限公司 | A related substance of Frellaner and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107501199A (en) | The extraction of fluorine thunder Rana monomeric compound and purification process | |
CN1883275B (en) | A botanical antibiotic and application thereof | |
CN101371831B (en) | Use of Fructus arctii aglycone in medicament for killing ectoparasite of aquatic animal | |
CN108651465B (en) | Application of iridoid glycoside in preparation of pesticide | |
Zhang et al. | Action modes of Aloe vera L. extracts against Tetranychus cinnabarinus Boisduval (Acarina: Tetranychidae) | |
CN101813684B (en) | Biological test method of mirid resisting effect of cotton secondary metabolite | |
CN104987329A (en) | Dihydroagarofuran type sesquiterpene compound and preparing method and application thereof | |
CN102007944A (en) | Plant source synergistic compound aphicide and acaricide containing rotenone and preparation method thereof | |
CN106070346A (en) | A kind of have active substance and the application thereof gone out demodicid mite with drive demodicid mite effect | |
CN101099738B (en) | Application of sanguinarine in preparing aquatic animal medicine and method for preparing its preparation | |
CN115960053B (en) | Naphthalene isoxazoline compound and application thereof | |
CN1810123A (en) | Botanical pesticide prepared with calamus | |
CN110590463A (en) | A molluscicide for fertilizing and killing molluscs with double-effect organic fertilizer, its preparation method and its application | |
CN106124249A (en) | A kind of rice field wetland water sample acquisition device and collection water sample processing method | |
CN102334499B (en) | Application of isothiocyanate compound in preparing agricultural herbicide for controlling farmland weeds and lawn weeds | |
CN104059888A (en) | Noctuid granulosis virus, and preparation method and application of preparation containing virus | |
CN103315008B (en) | Preparation method of Suaeda salsa used as agricultural pesticide and application | |
CN114469932B (en) | 4-butene arctigenin and application thereof in killing fish ectoparasites | |
CN104365656B (en) | A kind of highly efficiency compositional composition pesticide containing MTI-446 | |
Xing et al. | Fumigation activity of essential oil of cinnamonum loureirii against red imported fire ant (Solenopsis invicta) Workers | |
Qing et al. | Acaricidal activity of Boenninghausenia sessilicarpa against Panonychus citri | |
CN101269066B (en) | Application of isopimpinellin in preparing fishery medicine and method for preparing its preparation | |
CN105994304A (en) | Application of novel insect cell immunosuppressor | |
CN106332892A (en) | Abamectin and spirotetramat compound suspending agent and preparation method thereof | |
CN116349706A (en) | Application of rice leaf extract in pest killing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171222 |